BYLTORO

Serial Number 90046921
Registration 6466595
700

Registration Progress

Application Filed
Jul 10, 2020
Under Examination
Jun 15, 2021
Approved for Publication
Apr 20, 2021
Published for Opposition
Apr 20, 2021
Registered
Aug 31, 2021

Trademark Image

BYLTORO

Basic Information

Serial Number
90046921
Registration Number
6466595
Filing Date
July 10, 2020
Registration Date
August 31, 2021
Published for Opposition
April 20, 2021
Drawing Code
4000

Status Summary

Current Status
Active
Status Code
700
Status Date
Aug 31, 2021
Registration
Registered
Classes
005

Rights Holder

Takeda Pharmaceuticals International AG

99
Address
Thurgauerstrasse 130
Glattpark-Opfikon 8152
CH

Ownership History

Takeda Pharmaceuticals International AG

Original Applicant
99
Glattpark-Opfikon CH

Takeda Pharmaceuticals International AG

Owner at Publication
99
Glattpark-Opfikon CH

Takeda Pharmaceuticals International AG

Original Registrant
99
Glattpark-Opfikon CH

Legal Representation

Attorney
Karl M. Zielaznicki

USPTO Deadlines

Next Deadline
770 days remaining
Section 8 (6-Year) Declaration Due (Based on registration date 2021-08-31)
Due Date
August 31, 2027
Grace Period Ends
February 29, 2028
Additional deadlines exist. Contact your attorney for complete deadline information.

Application History

26 events
Date Code Type Description Documents
Aug 31, 2021 R.PR A REGISTERED-PRINCIPAL REGISTER Loading...
Jul 27, 2021 DP1B I 1(B) BASIS DELETED; PROCEED TO REGISTRATION Loading...
Jul 19, 2021 AITU A CASE ASSIGNED TO INTENT TO USE PARALEGAL Loading...
Jun 25, 2021 D1BR I TEAS DELETE 1(B) BASIS RECEIVED Loading...
Jun 25, 2021 IUCN S NOTICE OF ALLOWANCE CANCELLED Loading...
Jun 15, 2021 NOAM E NOA E-MAILED - SOU REQUIRED FROM APPLICANT Loading...
Apr 20, 2021 PUBO A PUBLISHED FOR OPPOSITION Loading...
Apr 20, 2021 NPUB E OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Loading...
Mar 31, 2021 NONP E NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Loading...
Mar 17, 2021 CNSA P APPROVED FOR PUB - PRINCIPAL REGISTER Loading...
Mar 2, 2021 CRFA I CORRESPONDENCE RECEIVED IN LAW OFFICE Loading...
Mar 2, 2021 TEME I TEAS/EMAIL CORRESPONDENCE ENTERED Loading...
Feb 25, 2021 ALIE A ASSIGNED TO LIE Loading...
Nov 25, 2020 CNSL R SUSPENSION LETTER WRITTEN Loading...
Nov 25, 2020 GNSL S LETTER OF SUSPENSION E-MAILED Loading...
Nov 25, 2020 GNS3 O NOTIFICATION OF LETTER OF SUSPENSION E-MAILED Loading...
Nov 25, 2020 ERSI I TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED Loading...
Nov 10, 2020 TEME I TEAS/EMAIL CORRESPONDENCE ENTERED Loading...
Nov 9, 2020 TROA I TEAS RESPONSE TO OFFICE ACTION RECEIVED Loading...
Nov 9, 2020 CRFA I CORRESPONDENCE RECEIVED IN LAW OFFICE Loading...
Oct 26, 2020 CNRT R NON-FINAL ACTION WRITTEN Loading...
Oct 26, 2020 GNRT F NON-FINAL ACTION E-MAILED Loading...
Oct 26, 2020 GNRN O NOTIFICATION OF NON-FINAL ACTION E-MAILED Loading...
Oct 21, 2020 DOCK D ASSIGNED TO EXAMINER Loading...
Aug 6, 2020 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Loading...
Jul 14, 2020 NWAP I NEW APPLICATION ENTERED Loading...

Detailed Classifications

Class 005
Pharmaceutical preparations for use in oncology
First Use Anywhere: 0
First Use in Commerce: 0

Classification

International Classes
005